Last reviewed · How we verify
SODIUM BROMIDE
At a glance
| Generic name | SODIUM BROMIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible Bronchoscopy (PHASE2, PHASE3)
- SAINT: Safe Induction of Labor Trial (PHASE3)
- Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation With Moderate vs. Deep Neuromuscular Block (PHASE1)
- Hyoscine Butyl-bromide Versus Ondansetron for Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia (PHASE4)
- BUSCLAB - Buscopan to Prevent Slow Progress in Labor (PHASE3)
- Monthly Replacement Orthokeratology for Myopia Control in Young Children (NA)
- Monthly Replacement Orthokeratology for Myopia Control in Existing Lens Wearers (NA)
- Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SODIUM BROMIDE CI brief — competitive landscape report
- SODIUM BROMIDE updates RSS · CI watch RSS